Clinical Features, Management and Prognosis of Hepatic Sarcoidosis: Insights From a Nationwide Italian Study
Liver International · 2026
DOI: 10.1111/liv.70459 ↗Kurz gefasst
Multizentrische Studie in der Zeitschrift Liver International, 2026. Verfasst von Cristina Della Corte und 35 weiteren Autor:innen. Beteiligte Einrichtung: Gastroenterology Unit, Rho Hospital, ASST Rhodense, Rho, Italy. Hauptthemen laut MEDLINE: Sarcoidosis, Liver Diseases. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 50 Literaturangaben.
Abstract (Originalsprache)
Background and Aims Sarcoidosis is a rare systemic granulomatous disease involving the liver in up to 20% of cases. Data on hepatic sarcoidosis (HS) prevalence and management remain limited. This study aims to provide a comprehensive analysis of HS patients across Italy, focusing on diagnostic pathways, management strategies, and prognostic factors.
Methods
This multicenter retrospective study, conducted from April 2022 to December 2023, includes data from 36 hepatology units, affiliated with the Italian Association for the Study of the Liver (AISF), invited to analyse consecutive cases of HS reported between 2003 and 2023.
Results
A total of 78 patients with HS were identified, with complete data available for 58 (median age 53 years; 57% female; 81% Caucasian), prospectively followed for a median of 41 months. Pulmonary and lymphatic involvement were present in 45% and 34% of cases, respectively. Isolated hepatic involvement was seen in 10%. Liver biopsy revealed granulomas in all specimens. Histological cirrhosis and clinically significant portal hypertension (CSPH) were observed in 10% and 14% of patients, respectively. Patients with CSPH had a significantly higher body mass index (BMI) compared to those without (33 vs. 25, p = 0.002). Steroids and ursodeoxycholic acid were the first‐line treatments for 80% and 28% of patients, respectively, while 29% required second‐line therapies. One patient died from liver‐related complications.
Conclusions
This nationwide study underscores the variability in HS presentation and management across Italy. Liver biopsy remains essential for diagnosis and staging. While steroids are the primary treatment, many patients require second‐line therapies. Our finding of a higher BMI in patients with CSPH suggests that metabolic factors may play a role in disease progression, warranting further investigation.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Gastroenterology Unit, Rho Hospital, ASST Rhodense, Rho, Italy.
- Division of Gastroenterology, Center for Autoimmune Liver Diseases, European Reference Network on Hepatological Diseases (ERN RARE-LIVER), IRCCS Fondazione San Gerardo dei Tintori, Monza, Italy.
- University of Turin, Turin, Italy.
- National Center for Rare Diseases, National Institute of Health, Roma, Italy.
- Unit of Internal Medicine and Hepatology, Department of Medicine, Azienda Ospedale Università Padova, Padova, Italy.
- European Reference Network-ERN RARE-LIVER, Department of Medicine, Azienda Ospedale-Università Padova, Padova, Italy.
ORCID-Profile: Cristina Della Corte, Nicola Pugliese, Elisabetta Degasperi, Alessandro Federico, Lorenzo Surace, Marco Silano, Pietro Invernizzi, Alessio Aghemo, Germana de Nucci
Zitieren
APA
Della Corte, C., D'Amato, D., Rocchetti, A., Martini, A., Morelli, M. C., Terracciani, F., Campigotto, M., Pugliese, N., Pieri, G., Simone, L., Malinverno, F., Degasperi, E., Reati, R., Federico, A., Gallo, R., Colarossi, C., Svegliati-Baroni, G., Morana, E., Rapetti, R., …, & Carbone, M. (2026). Clinical Features, Management and Prognosis of Hepatic Sarcoidosis: Insights From a Nationwide Italian Study. Liver International. https://doi.org/10.1111/liv.70459
Vancouver
Della Corte C, D'Amato D, Rocchetti A, Martini A, Morelli MC, Terracciani F, et al. Clinical Features, Management and Prognosis of Hepatic Sarcoidosis: Insights From a Nationwide Italian Study. Liver International. 2026. doi:10.1111/liv.70459
BibTeX
@article{DellaCorte2026,
author = {Della Corte, Cristina and D'Amato, Daphne and Rocchetti, Adele and Martini, Andrea and Morelli, Maria Cristina and Terracciani, Francesca and Campigotto, Michele and Pugliese, Nicola and Pieri, Giulia and Simone, Loredana and Malinverno, Federica and Degasperi, Elisabetta and Reati, Raffaella and Federico, Alessandro and Gallo, Raffaella and Colarossi, Chiara and Svegliati-Baroni, Gianluca and Morana, Ester and Rapetti, Rachele and Surace, Lorenzo and Arena, Ilaria and Perricone, Giovanni and Ferrari, Gianluca and Silano, Marco and Torreri, Paola and Invernizzi, Pietro and Vespasiani-Gentilucci, Umberto and Aghemo, Alessio and Giannini, Edoardo Giovanni and Durante-Mangoni, Emanuele and Missale, Gabriele and Saibeni, Simone and de Nucci, Germana and Manes, Giampiero and Viganò, Mauro and Carbone, Marco},
title = {Clinical Features, Management and Prognosis of Hepatic Sarcoidosis: Insights From a Nationwide Italian Study},
journal = {Liver International},
year = {2026},
doi = {10.1111/liv.70459}
}
EUVIMED